|
HNRNPD expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.05160324892495E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.84929976782189E-10 |
| Normal-vs-Stage2 |
4.16540000269805E-08 |
| Normal-vs-Stage3 |
5.57598411887739E-12 |
| Normal-vs-Stage4 |
2.66964228501365E-12 |
| Stage1-vs-Stage2 |
2.780800E-01 |
| Stage1-vs-Stage3 |
2.253900E-02 |
| Stage1-vs-Stage4 |
8.537700E-03 |
| Stage2-vs-Stage3 |
5.852200E-01 |
| Stage2-vs-Stage4 |
4.172400E-01 |
| Stage3-vs-Stage4 |
7.194400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.61408689034215E-12 |
| Normal-vs-AfricanAmerican |
2.917300E-03 |
| Normal-vs-Asian |
9.21589999980377E-07 |
| Caucasian-vs-AfricanAmerican |
1.104990E-01 |
| Caucasian-vs-Asian |
2.502400E-01 |
| AfricanAmerican-vs-Asian |
4.919200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.76869996216089E-10 |
| Normal-vs-Female |
6.28308516326115E-12 |
| Male-vs-Female |
9.552400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.49890000411546E-08 |
| Normal-vs-Age(41-60Yrs) |
6.89415191601483E-12 |
| Normal-vs-Age(61-80Yrs) |
1.08030251411151E-11 |
| Normal-vs-Age(81-100Yrs) |
2.840600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.824610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.240300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.808200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.401000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.917000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.585200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.832700E-04 |
| Classical-VS-Follicular |
1.523720E-02 |
| Classical-VS-Other |
7.633800E-01 |
| Classical-VS-Normal |
1.31860000696093E-09 |
| Tall-VS-Follicular |
2.627200E-01 |
| Tall-VS-Other |
1.795610E-01 |
| Tall-VS-Normal |
9.93209958721764E-11 |
| Follicular-VS-Other |
5.875600E-01 |
| Follicular-VS-Normal |
3.66049968114623E-10 |
| Other-VS-Normal |
7.822400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.27942101357803E-12 |
| Normal-vs-N1 |
3.19369997114904E-09 |
| N0-vs-N1 |
8.705200E-01 |
|
|
